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Hepatitis C Virus (HCV) non-structural proteins are major components of replication
complex that is modulated by several host factors. We previously reported that
nucleolin, a representative nucleolar marker, interacts with the NS5B through two
separated sequences, amino acids (aa) 208–214 and 500–506, and that W208 in the
former stretch is essential for both nucleolin-binding and HCV replication. Here we
evaluated the role of the latter stretch aa 500–506 of WRHRARS in nucleolin-binding
and HCV replication scanned by alanine-substituted clustered mutant (cm) or point
mutant (pm). One tryptophan and three arginine residues in the sequence were
found to be essential both for nucleolin-binding in vivo and HCV replication detected
with a HCV subgenomic replicon transfected into Huh7 cells. NS5B-binding of
nucleolin was further delineated by truncation and clustered mutants of nucleolin.
Arginine-glycine-glycine (RGG) repeat in the Glycine arginine rich (GAR) domain
were defined to be indispensable for NS5B-binding immunologically detected in
in vivo and in vitro although short internal-truncations of RGG repeat are tolerable
for NS5B-binding. These results indicate that nucleolin is a critical host factor for
HCV replication through the direct interaction between W208 and several residues at
the sequence, aa 500–505, of NS5B, and the long-turn motif including RGG repeat at
nucleolin C-terminal.
Key words: HCV, NS5B, nucleoli, nucleolin, RGG.
Abbreviations: GAR, glycine arginine rich; HCV, hepatitis C virus; NS, non-structural; PBS, phosphate-
buffered saline; PMSF, phenylmethylsulphonyl fluoride; RBD, RNA-binding domain; RdRp, RNA-dependent
RNA polymerase; RGG, arginine-glycine-glycine.
The Hepatitis C virus (HCV) is a major cause of chronic
hepatitis around the world (1, 2) Chronic infection with
HCV can progress to cirrhosis, end-stage liver disease
and hepatocellular carcinoma (3–5) HCV is classified in
the genus Hepacivirus of the family Flaviviridae. It
contains a single-stranded, and positive-sense RNA
genome, 9.6 kb in length, which composed of a 50 non-
translated region (50NTR), a single open reading frame
(ORF), and a 30NTR. The 50NTR contains an internal
ribosome entry site (IRES), which mediates the transla-
tion of a single large polyprotein of 3000 amino acid
residues (6, 7). During and after translation, the
polyprotein is cleaved in the structural region by host
cell enzymes, and the viral non-structural (NS) proteins
are cleaved by viral proteases, giving rise to at least 10
different products, including the structural proteins, core
protein, E1, E2, and followed by p7, and the NS proteins
NS2, NS3, NS4A, NS4B, NS5A and NS5B (8–11). The
30NTR has a tripartite structure, consisting of a variable
region following the stop codon of the O0RF, a poly (U)-
poly (UC) tract of variable length, and a highly conserved
98-nucleotide-long sequence designated the X tail, which
is critical for HCV RNA replication and HCV infection
(12–15).
HCV is unique among positive-strand RNA viruses in
that it causes persistent and chronic infections. In
addition, the high mutation rate of the gene encoding
the E2 envelope protein allows it to escape host immune
surveillance, which is strongly associated with chronic
inflammation of the liver (16–19). As a result, HCV
replication has become a target for treatment of
chronically infected individuals. The RNA-dependent
RNA polymerase (RdRp) NS5B is the core catalytic
enzyme for HCV RNA replication. Several recombinant
and catalytically active forms of NS5B have been
expressed in and purified from insect cells and
Escherichia coli, and these proteins have provided
insights into the biochemical and catalytic properties of
NS5B (20–23). Although studies of HCV replication
in vitro have provided the critical information on the
catalytic properties of NS5B, but they are limited in
elucidating the molecular mechanism of in vivo HCV
replication, since replication requires all or most NS
proteins and/or host proteins and occurs at the specia-
lized loci on the host cell membrane. Studies on the
biology of HCV replication have been facilitated by the
development of subgenomic and full-length HCV
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replicons, which express HCV proteins and replicate
their RNA when transfected into a human hepatoma cell
line, Huh7 cells, and other cell lines (24–26).
Nucleolin is an abundant protein of nucleolus and
major nucleolar phosphoprotein that has been implicated
in rDNA transcription, rRNA maturation, ribosome
assembly and nucleolin specific antibodies have been
used immunohistochemically to identify nucleoli (27–29).
Nucleolin has been shown to be an RNA chaperone and/
or shuttling protein for various host and viral compo-
nents in the nucleoli, nucleoplasm, cytoplasm and the
plasma membrane (30–32). Nucleolin seems to be
composed of several modules. The amino terminal third
of this protein contains alternating acidic and basic
domains defined as nuclear localization signals (NLS), its
middle part includes four consensus RNA-binding
domains (RBD), and its carboxy-terminus is a distinctive
glycine/arginine-rich (GAR) domain with several
arginine-glycine-glycine (RGG) motifs. The biological
role of the GAR domain remains uncertain although it
was reported to interact with several factors including
ribosomal proteins (33). We previously reported that the
transient expression of NS5B caused the redistribution of
endogenous nucleolin from the nucleolus to the cyto-
plasm, and that nucleolin and NS5B interact with each
other in vivo and in vitro through two independent
regions of NS5B, amino acids (aa) 208–214 and 500–506.
Truncated nucleolin constructs having the C-terminal
part could inhibit NS5B RdRp activity in vitro (34) in the
situation that recombinant full-length nucleolin is not
available. The result supported the relevance of the
interaction, but it may not reflect the exact role of the
interaction in vivo that remains elucidated (35).
To further evaluate the interaction of nucleolin and
NS5B in HCV replication, we have focused on NS5B aa
500–506, and prepared a series of mutant NS5B proteins
and replicons, in which each amino acid within the
sequence was substituted to alanine(s). Here we report
that the W500, R501, R503 and R505 residues are
critical for, binding to nucleolin in vivo as well as for
transient HCV replication.
To gain further insight into the NS5B-binding
region of nucleolin, we prepared the various
truncated and clustered mutated nucleolin constructs of
the GAR domain harbouring the RGG repeats. We show
that the long-turn motif harbouring the RGG repeat
domain is indispensable for NS5B binding in vivo and
in vitro.
EXPERIMENTAL PROCEDURES
Construction of Plasmids—The plasmid pNNRZ2RU
(36) harbours a subgenomic replicon derived from the cell
line MT-2C infected with HCV (genotype 1b, GenBankTM
Accession Number AB080299, M1LE isolate) and con-
tains M1LE/S232I, MA cDNA. MA is a replicon contain-
ing a neomycin resistance gene and the point mutation
S232I in NS5A and was used as a wild-type replicon in
this study (37). The plasmid pNNRZ2RU/S232I was
digested with BglII and XbaI, and the obtained
fragment was inserted into the BglII and XbaI sites of
the vector pGL3 Basic (Promega) to create the plasmid
pGL3-BglII-XbaI, which was used as an intermediate
vector. All mutations of NS5B were introduced into the
plasmid pGL3-BglII-XbaI. The plasmid containing each
mutation was digested with BglII and XbaI, and the
fragment was reinserted into the BglII and XbaI sites of
pNNRZ2RU/S232I to create each mutant replicon cDNA.
The plasmids pNNRZ2RU/S232I and each mutant
pNNRZ2RU/S232I were used as templates for replicon
RNA, MA and mutant MA, respectively.
The mammalian expression vectors pNKFLAG and
pNKGST (38) were used to express amino-terminally
FLAG- and GST-tagged proteins, respectively.
The plasmid pNNRZ2RU/S232I was subcloned by PCR
using the set of the primers, 50-TATCGAGCTCGATGTC
AATGTCCTACTCATGGACAGGT-30 (NS5B For), which
contains an artificial initiation codon downstream of the
SacI site, and 50-ATGGATGGATCCGCGGGGTCGGGCG
CGAGACAGGCT-30 (NS5Bt Rev), which contains a
BamHI site. The amplified fragment, NS5Bt, containing
full-length NS5B truncated by 21 aa at the C-terminus,
was subcloned into the SacI and BamHI sites of
pNKFLAG and pNKGST to create pNKFLAG/NS5Bt
and pNKGST/NS5Bt, respectively.
To express FLAG-tagged mutant NS5Bt proteins,
single substitution mutants of NS5B (W500A, R501A,
H502A, R503A, R505A, S506A, W500S, W500F and
W500Y), and a clustered alanine substitution mutant
within aa 500–506, cm503, were constructed by introdu-
cing each mutation into the Cfr9I and HindIII sites of
pNKFLAG/NS5Bt by site-directed mutagenesis using
primers carrying the necessary nucleotide changes.
To create individual intermediate vectors pGL3-BglII-
XbaI, harbouring each of these point substitution
mutants of NS5B and cm503, the fragment of
pNKFLAG/NS5Bt containing each NS5B mutation was
introduced into the Eco81I and HindIII sites of pGL3-
BglII-XbaI. The BglII-XbaI fragment of pGL3-BglII-XbaI
containing each mutation was subsequently ligated into
the BglII and XbaI sites of pNNRZ2RU/S232I to create
each mutant replicon cDNA.
The plasmid pLMH14 (39) harbours a replicon cDNA
in which the neomycin resistance gene of pNNRZ2RU/
S232R was replaced by a luciferase gene. The expression
plasmids of these point mutants (pm) and clustered
mutants (cm) 503 in pLMH14 were constructed by
introducing the BglII-XbaI fragments of pNNRZ2RU/
S232I harbouring individual NS5B mutations into the
BglII-XbaI sites of pLMH14. The plasmids pLMH14,
pLMH14/GHD (39) and pLMH14 containing each NS5B
mutation were used as templates for replicon RNA,
LMH14, LMH14/GHD and mutant LMH14, respectively.
To express a series of truncated nucleolin mutants, we
used mammalian expression vectors which have been
described previously (34). To create the plasmids encod-
ing each FLAG-tagged mutant nucleolin, internal-trun-
cated and alanine-substitution mutations within the
nucleolin RGG motif were inserted into the HindIII
and BamHI sites of pNKFLAG-nucleolin1234R (34). The
main primers used to generate the nucleolin mutants are
shown in Table 1.
The sequences of all of the constructs were confirmed
by the dideoxy sequence method.
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Cell Culture—The COS cells were used for immuno-
precipitation assays. To monitor HCV RNA replicons, we
used two kinds of Huh7 cells, one derived from our
laboratory’s original Huh7 cell line, designated Huh7-
DMB (40), and the other cured cell line by IFN of MH14,
designated cured MH14 (39). Both types of Huh7 cell
were grown as described (40). Huh7-DMB was used for
colony formation assay, and cured MH14 for luciferase
assay.
In vitro Transcription and Purification of RNA—All
plasmids harbouring replicon cDNA were linearized with
XbaI and purified by passage through a column (DNA
purification kit; Promega). Replicon RNA was synthe-
sized and purified as described (40).
RNA Transfection and Selection of G418 Resistant
Cells—RNA was transfected by electroporation as
described (40, 41). To select G418-resistant cells, the
medium was replaced with fresh medium containing
1 mg/ml of G418 (Geneticin; Gibco-BRL, Invitrogen
Life Technologies) 24 h after transfection and the
medium was changed twice a week. Finally 3 weeks
after transfection, the colonies were stained with
Coomassie brilliant blue (0.6 g/l in 50% methanol-10%
acetic acid).
RNA Transfection and Luciferase Assay—RNA trans-
fection for luciferase-replicon RNA was performed in
using DMRIE-C reagent (Invitrogen Life Technologies),
as described (41). Cell proteins were extracted in a lysis
buffer supplied in the Dual-Luciferase Reporter Assay
System (Promega), and their luciferase activity was
measured. Each assay was performed at least in
triplicate, and means and standard deviations were
determined.
DNA Transfection—DNA transfection was performed
using the calcium phosphate precipitation method as
reported previously (23).
Co-transfection of Replicon RNA and Plasmid DNA—
24 h after transfection of luciferase-replicon RNA, plas-
mid DNAs with 100 ng per 1 well of 48-well plate were
transfected into cured MH14 cells using FuGENE6
transfection reagent (Roche Applide Science), according
to the manufacturer’s recommendations. 24 h and 72 h
after RNA transfection, luciferase assay was done as
described earlier.
Preparation for Cell Extracts, Co-precipitation with
GST Resin, and Western Blot Analysis—Transient
transfection of COS1 cells, an immortalized cell line of
African green monkey kidney cells, was performed as
described (42, 43). The transfected cells were harvested,
washed with phosphate-buffered saline (PBS) () and
sonicated in lysis buffer (50 mM Tris–HCl, pH7.5,
150 mM NaCl, 1 mM EDTA, 10% glycerol, 1 mM phenyl
methyl sulphonyl fluoride (PMSF), 10 mM leupeptin and
aprotinin, and 1 mM DTT). Total cell lysate was diluted
15-fold with lysis buffer, mixed with 10 ml of glutathione-
Sepharose 4B beads, and then incubated for 3 h on a
rotator in a cold room. After an extensive wash with PBS
() containing 1.0% Triton X-100, the bound proteins
were eluted, fractionated by sodium dodecyl sulphate
(SDS)-12% polyacrylamide gel electrophoresis (PAGE),
transferred to nitrocellulose membranes, and subjected
to Western blot analysis with anti-FLAG M2 monoclonal
antibody.
The proteins were visualized by enhanced chemilumi-
nescence according to the manufacturer’s instructions
(Amersham Biosciences). The nitrocellulose membranes
used for Western blot analysis with anti-FLAG M2
antibody were reprobed with anti-GST monoclonal anti-
body (Zymed Laboratories), according to the manufac-
turer’s instructions (Amersham Biosciences).
RESULTS
Interaction between Nucleolin and Substituted Mutants
of NS5B—We previously reported that NS5B from JK-1
isolate binds to nucleolin through its two regions, aa
208–214 and 500–506, and that NS5B from M1LE
isolate binds to nucleolin as same as JK-1 isolate, and
aa 208–214 is essential for this interaction in M1LE
isolate (34). Although it remained to be uncertain
whether NS5B from M1LE isolate could bind nucleolin
through its aa 500–506. To determine the essential
regions/residues of NS5B required for its binding to
nucleolin, we prepared FLAG-NS5Bt/cm503, in which all
seven aa 500–506 from M1LE isolate were replaced by
alanine residues and FLAG-NS5Bt/pmW500A, R501A,
H502A, R503A, R505A and S506A, in which each
individual amino acid residue was changed to alanine
(except for aa 504, which is alanine in the wild-type
Table 1. Sequence of the primers used in this study.
Primer Sequence
RGG Del 1 (aa 653–668) For:50-GGTGAAGGTGGCTTCGGGGGTGGTAGAGGAGGCCGAGGAGGA-30
RGG Del 1 (aa 653–668) Rev:50-TCCTCCTCGGCCTCCTCTACCACCCCCGAAGCCACCTTCACC-30
RGG Del 2 (aa 666–678) For:50-GCCTCCTCGCCCTCCAAAGCCTCCACCACCTCGTCCTCCAAAGCCGCC-30
RGG Del 2 (aa 666–678) Rev:50-GGCGGCTTTGGAGGACGAGGTGGTGGAGGCTTTGGAGGGCGAGGAGGC-30
RGG Del 3 (aa 679–691) For:50-CGAGGAGGATTTGGTGGCAGAGGCCGGGGAGGAGGAGGTGACCACAAG-30
RGG Del 3 (aa 679–691) Rev:50-CTTGTGGTCACCTCCTCCTCCCCGGCCTCTGCCACCAAATCCTCCTCG-30
RGG Del 12 (aa 653–678) For:50-GGTGAAGGTGGCTTCGGGGGTGGAGGCTTTGGAGGGCGAGGA-30
RGG Del 12 (aa 653–678) Rev:50-TCCTCGCCCTCCAAAGCCTCCACCCCCGAAGCCACCTTCACC-30
RGG Del 123 (aa 653–691) For:50-GGTGAAGGTGGCTTCGGGGGTGGAGGAGGAGGTGACCACAAG-30
RGG Del 123 (aa 655–691) Rev:50-CTTGTGGTCACCTCCTCCTCCACCCCCGAAGCCACCTTCACC-30
RGG Del 4 (aa 643–702) For:50-GACTGGGCCAAGACGAAGTTTGAA-30
RGG Del 4 (aa 643–702) Rev:50-CCCCGGATCCTTCAAACTTCGTCTTGGCCCAGTCCAAGGTAAC-30
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sequence) (Fig. 1A). GST-nucleolin 1234R and the
recombinant FLAG-tagged NS5Bt, a soluble form of
NS5B missing the C-terminal 21 aa (23) that is not
essential for this interaction (34), were coexpressed in
COS cells. In this study we used nucleolin 1234R missing
N-terminal (NLS region) since the expression level of the
construct is better than that of full-length and we have
shown that the NLS is not essential for binding to NS5B
(34). The cell lysates were subjected to GST pull-down
assays, and the bound proteins were fractionated by
SDS–PAGE and immunologically detected with anti-
FLAG M2 and anti-GST antibodies (Fig. 1B upper,
middle and lower panels). FLAG-NS5Bt/cm503 did not
bind GST-nucleolin (Fig. 1B upper panel), indicating that
aa 500–506 in both isolates is critical for binding to
nucleolin. The NS5B protein harbouring alanine sub-
stitution at W500, R501, R503 or R505 failed to bind
GST-nucleolin 1234R, although that with H502A and
S506A could bind it as like the wild one (Fig. 1B upper
panel).
Scanning of aa 500–506 of NS5B in HCV Subgenomic
Replicon—We previously showed that the sequence aa
500–506 is one of two amino acid stretches critical for
nucleolin-binding (34). To determine the importance of
this sequence in HCV replication, we used the HCV RNA
subgenomic replicon, MA, in which the serine residue at
aa 232 of NS5A had been replaced by isoleucine (S232I),
because MA could replicate more efficiently than the
original construct in Huh7-DMB cells (37, 40). The
replicon MA/NS5Bcm503, in which all 7 aa of NS5B
were changed to alanine, and MA/W500A, R501A,
H502A, R503A, R505A and S506A in which each
individual amino acid residue was changed to alanine
(except for aa 504, which is alanine in the wild-type
sequence), were individually transfected into Huh7-DMB
cells, and the cells were cultured in the presence of G418
(Fig. 2A). We observed G418 resistant colonies in the
cells transfected with MA/S506A, but not in the cells
transfected with a RNA replicon having one of the other
five point mutations or with MA/cm503, or in the
negative control, the mutant replicon M1LE/VDD defec-
tive in RdRp (40, 41). These findings indicate that all the
residues except S506 of the NS5B sequence, aa 500–506,
are all critical for replication (Fig. 2B and C). The non-
critical role of S506 of NS5B in HCV replication seems to
be consistent to the fact that not S506 but A506 is more
often used among the HCV isolates (Fig. 3).
Transient Replication of HCV Replicons Carrying
Luciferase Reporter Gene—To further confirm these
results, we evaluated the effect of these mutations in
HCV replication using a transient replication assay with
a replicon in which the neomycin-resistant gene was
replaced by a luciferase gene. Using this system, the
luciferase activity in a lysate of transfected cells could be
used to directly monitor HCV RNA replication, as the
copy number of the reporter gene should be determined
by the level of replicaion of the replicon. We introduced
the several point mutations into NS5B aa 500–506 in
LMH14 (Fig. 4A) and measured luciferase activity of the
lysates 24 h and 72 h after transfection. The activity at
24 h was used to monitor the efficiency of each transfec-
tion, and the ratio of the activity at 72 h to that at 24 h
was used to monitor the extent of HCV replication. As
shown in Fig. 4B, the ratio was high when a subline of
Huh7 cells, cured MH14, was transfected with a wild–
type replicon, LMH14 RNA, whereas it was low with
LMH14/GHD, a mutant RNA replicon of LMH14 defec-
tive in RdRp activity. The relative ratio of the luciferase
activities was low with all the tested mutants except
LMH14/S506A, with which the ratio is the same as in
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Fig. 1. Interaction between nucleolin and NS5B and
essential residue of NS5B for this interaction. COS cells
were transiently co-transfected with plasmids expressing FLAG-
NS5Bt proteins (lanes 1 and 2, wild-type; lane 3, W500A; lane 4,
R501A; lane 5, H502A; lane 6, R503A; lane 7, R505A; lane 8,
S506A; lane 9, cm503; lane 10, cm211; lane 11, FLAG protein
alone, respectively), and GST protein alone (lane 1) or GST-
nucleolin1234R protein (lanes 2–11). (A), Schematic representa-
tion of FLAG-tagged mutant NS5Bts. To express each mutant
NS5B protein, we introduced each mutation into pNKFLAG/
NS5Bt (wild). (B), GST pull-down assay and Western blot
analysis were carried out with anti FLAG antibody and anti
GST antibody. Upper panel is output of FLAG-NS5Bt proteins.
Co-precipitants on glutathione resin were washed with PBS ()
containing 1.0% Triton X-100, fractionated by SDS-12% PAGE,
and subjected to Western blot analysis with anti-FLAG M2
monoclonal antibody. Middle panel is input of FLAG-NS5Bt
proteins. Total lysates were fractionated by SDS-12% PAGE and
subjected to Western blot analysis with anti-FLAG M2 mono-
clonal antibody. Lower panel is recovery of GST or GST-
nucleolin 1234R proteins. The nitorocellulose used for Western
blot analysis of co-precipitants with anti-FLAG M2 antibody was
re-probed with anti-GST antibody. Molecular masses (kDa) are
indicated on the left of each panel.
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This result is well consistent to that with the cm and pm
mutations monitored by the colony formation assay
(Fig. 2B and C).
Dissection of the C-terminal Region of Nucleolin
Critical for HCV NS5B-binding in vivo—We previously
mapped the region of nucleolin necessary for NS5B-
binding within the RBD4-GAR region (4R) as the FLAG-
4R protein exhibited the ability to bind GST-NS5B of
JK1 isolate (34). To further map the NS5B-binding
region within RBD4-GAR, we prepared the mutant
nucleolin in which RBD4 was internally deleted. This
mutant could bind NS5B, indicating that GAR, not RBD4
would be the essential region for this binding (data not
shown) and then GAR domain was further delineated
with several truncated and internal-deletion constructs
within the domain (Fig. 5A). COS cells were transfected
with wild-type or mutated FLAG-nucleolin 1234R,
together with GST-NS5Bt or GST, the cell lysates were
subjected to GST pull-down, and the bound proteins were
immunologically detected with anti-FLAG M2 and anti-
GST antibodies. We found that nucleolin 1234R and
three nucleolin internal-truncation mutants, 1234R
Del653-665, 1234R Del666-678 and 1234R Del679-691,
were bound to GST-NS5Bt, whereas all mutants missing
the GAR domain, namely the internal-truncation
mutants 1234R Del653-678, 1234R Del653-691 and
1234R Del643-702, did not bind GST-NS5Bt (Fig. 5B
upper, middle and lower panel). To confirm the critical
role of the RGG repeats of nucleolin in NS5B binding,
the bacterial recombinant FLAG-tagged nucleolin 1234R
and mutant nucleolin-1234R proteins were prepared and
subjected to GST pull-down assays using GST-tagged
NS5Bt. The wild-type construct could bind NS5Bt, but
the mutants missing the long-turn motif at the GAR
domain could not (data not shown), indicating that the
long-turn motif harbouring the RGG repeats is critical
for binding to NS5B. As truncation analysis may affect
the integrity of the secondary structure of the region, a
version of alanine substitution mutants were constructed
to further delineate the sequences critical for
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Fig. 2. Effect of NS5B mutations within nucleolin-binding
region on the HCV RNA replication. The 0.5 mg of each
in vitro transcribed RNA were transfected into 4.0 106 Huh7-
DMB cells by electroporation. G418-resistant cells were selected
with 1 mg/ml G418 and stained 3 week later. The numbers of
G418 resistant cell colony were used as the indications of HCV
RNA replication. (A) Schematic representation of the HCV
mutant replicons used in this study. MA is a replicon carrying
the point mutation S323I in NS5A and was used as wild-type
replicon. The mutant replicons, MA/W500A, MA/R501A, MA/
H502A, MA/R503A, MA/R505A MA/S506A and MA/cm503 carry
each NS5B mutations as shown. Numbering starts from the
beginning of NS5B. (B) Visualization of G418-resistant colonies.
The protocol is described in EXPERIMENTAL PROCEDURES.
(C) This figure shows the mean number of G418-resistant cell
colonies per 10-cm-diameter cell culture dish per 0.5mg each
replicon RNA. Error bars indicate the standard deviations of the
results from at least three independent experiments. M1LE/
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Fig. 3. Partial sequence alignment among several geno-
types of HCV NS5B. Amino acid residues common to all
genotypes are denoted by asterisks below the sequence. The
sequence were obtained from HCV-1a (AF0096), HCV-1b
(AB016785), HCV-2a (D00944), HCV-2b (AB030907), HCV-3a
(AB031663), HCV-3b (D49374), HCV-4a (Y11604), HCV-5a
(Y13184), HCV-6a (Y12083), HCV-7b (D84263), HCV-8b
(D84264), HCV-9a (AB016785), HCV-10a (D63821) and HCV-
11a (D63822).
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All of arginine (R) or phenyl alanine (F) residues of three
subregions in the nucleolin GAR domain were scanned
by introducing alanine substitutions (Fig. 6A). Nucleolin
1234R cm1 (all R and F residues within aa 653–665 were
substituted to alanine), cm2 (all R and F residues were
substituted within aa 666–678) and cm3 (all R and F
residues were substituted within aa 679–691), exhibited
binding ability to GST-NS5Bt, whereas cm12 (all R and
F residues were substituted within aa 653–678) and
cm123 (all R and F residues were substituted within aa
653–691) did not bind or weakly bound to GST-NS5Bt
(Fig. 6B upper, middle and lower panel). All of these cm
nucleolin mutants in the FLAG-fused form were
expressed at the similar level in transiently transfected
COS cells (Fig. 6B middle panel). The results confirmed
that the long RGG repeat of nucleolin in the GAR
domain is contributing to the binding ability of nucleolin
to NS5B (Fig. 5B).
Effect of Wild and Truncated Mutant Nucleolin on
HCV Replication—To evaluate whether nucleolin
affects HCV replication by its binding to NS5B. The
FLAG tagged plasmid DNA which encode nucleolin full-
length, N terminal (NLS) alone, RBD1234GAR (Nuc
1234R), RBD1234 (Nuc 1234), RBD4GAR (Nuc 4R), and
GAR (Nuc R) alone were transiently coexpressed
with LMH14. However, neither wild-type nor the
truncated nucleolin mutants, had much effect on lucifer-
ase activity (Fig. 7). Similarly the transiently coex-
pressed nucleolin construct missing 4R or R could not
affect much HCV replication in the HCV subgenomic
replicon system (data not shown). The result suggests
that transient overexpression of truncated nucleolin
mutants may not efficiently compete out endogenous
nucleolin that is in excess to be required for HCV
replication in the cells.
DISCUSSION
Nucleolin is involved in a variety of cellular functions,
including RNA metabolism, regulation of chromatin
structure, trafficking of telomerase and transcriptional
regulation (29, 45–49). We previously reported the direct
interaction of NS5B and nucleolin through two sequences
(aa 208–214 and aa 500–506) of NS5B and the
C-terminus of nucleolin in vivo and in vitro (34), and
the important role of W208 within aa 208–214 of NS5B
for both HCV replication and nucleolin-binding (41).
These results strongly support the notion that nucleolin
is critical for HCV replication. To gain further insights
into the role of nucleolin in HCV replication, here we
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Fig. 4. Effect of NS5B mutations within the nucleolin-
binding region on transient HCV RNA replication.
(A) Schematic representation of the luciferase replicon. In the
LMH14 replicon, the neomycin resistance gene of replicon MA
was replaced by a luciferase gene and S232 of NS5A was replaced
by R. In the LMH14/GHD replicon, the NS5B GDD motif in
LMH14 was changed to GHD, and used as a negative control. The
mutant LMH14 replicons W500A, R501A, H502A, R503A, R505A,
S506A and cm503, carry the NS5B mutations shown. Numbering
starts from the beginning of NS5B. (B) Cured MH14 cells were
transfected with in vitro transcribed LMH 14 or LMH14 mutant
replicons, using DMRIE-C reagent, and luciferase activity
(relative light units; RLU) was measured 24 and 72 h after
transfection. Shown are the rations of activity (%) at 72 h relative
to 24 h. Error bars indicate the standard deviations of the results
from at least three independent experiments.
Fig. 5. Interaction between NS5Bt and mutant
nucleolin1234R and essential regions of nucleolin for this
interaction. COS cells were transiently co-transfected with
plasmids expressing mutant FLAG-nucleolin1234R proteins and
GST protein alone or GST-NS5Bt protein. (A) Schematic diagram
of wild-type nucleolin protein and deletion mutants. The secondary
structure within the nucleolin RGG domain predicted by DNASIS
(HITACHI) software is shown in upper panel. A series of internal
deletion mutants are shown. (B) GST pull-down assay and
Western blot analysis were carried out with anti FLAG antibody
and anti GST antibody. Upper panel is output of FLAG-nucleolin
1234R proteins. Co-precipitants on glutathione resin were washed
with lysis buffer, fractionated by SDS-12% PAGE and subjected to
Western blot analysis with anti-FLAG M2 monoclonal antibody.
Middle panel is input of FLAG-nucleolin 1234R proteins. Total
lysates were fractionated by SDS-12% PAGE and subjected to
Western blot analysis with anti-FLAG M2 monoclonal antibody.
Lower panel is recovery of GST or GST-NS5Bt proteins. The
nitrocellulose used for Western blot analysis of co-precipitants with
anti-FLAG M2 antibody was re-probed with anti-GST antibody.
Molecular masses (kDa) are indicated on the left. NLS, nuclear
localization signal; RBD, RNA binding domain RGG; arginine/
glycine rich domain; H, helix; S, sheet; T, turn.
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GAR   :MEDGEIDGNKVTLDWAKPKGEGGFGGRGGGRGGFGGRGGGRGGRGGFGGRGRGGFGGRGGFRGGRGGGGDHKPQGKKTKFE*
cm1   :MEDGEIDGNKVTLDWAKPKGEGGFGGAGGGAGGAGGAGGGRGGRGGFGGRGRGGFGGRGGFRGGRGGGGDHKPQGKKTKFE*
cm2   :MEDGEIDGNKVTLDWAKPKGEGGFGGRGGGRGGFGGRGGGAGGAGGAGGAGAGGFGGRGGFRGGRGGGGDHKPQGKKTKFE*
cm3   :MEDGEIDGNKVTLDWAKPKGEGGFGGRGGGRGGFGGRGGGRGGRGGFGGRGRGGAGGAGGAAGGAGGGGDHKPQGKKTKFE*
cm12  :MEDGEIDGNKVTLDWAKPKGEGGFGGAGGGAGGAGGAGGGAGGAGGAGGAGAGGFGGRGGFRGGRGGGGDHKPQGKKTKFE*
cm123 :MEDGEIDGNKVTLDWAKPKGEGGFGGAGGGAGGAGGAGGGAGGAGGAGGAGAGGAGGAGGAAGGAGGGGDHKPQGKKTKFE*






































































Fig. 6. Interaction of NS5Bt with clustered mutants (cm)
of nucleolin 1234R. COS cells were transiently co-transfected
with plasmids expressing FLAG-nucleolin 1234R proteins and
GST protein alone or GST-NS5Bt protein. (A) Schematic
diagrams of wild-type nucleolin and clustered mutants.
This figure shows a series of clustered mutants. All of arginine
and phenylalanine residues in three regions within nucleolin
GAR domain were substituted to alanines in each mutants. (B)
GST pull-down assay and Western blot analysis were carried out
with anti FLAG antibody and anti GST antibody. Upper panel is
output of FLAG-nucleolin 1234R proteins. Co-precipitants on
glutathione resin were washed with lysis buffer, fractionated by
SDS-12% PAGE and subjected to Western blot analysis with
anti-FLAG M2 monoclonal antibody. Middle panel is input of
FLAG-nucleolin 1234R proteins. Total lysates were fractionated
by SDS-12% PAGE and subjected to Western blot analysis with
anti-FLAG M2 monoclonal antibody. Lower panel is recovery of
GST or GST-NS5Bt proteins. The nitrocellulose used for Western
blot analysis of co-precipitants with anti-FLAG M2 antibody was
re-probed with anti-GST antibody. Molecular masses (kDa) are
indicated on the left.
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report that another essential NS5B sequence in nucleo-
lin-binding, aa 500–506, is indispensable for HCV
replication, and that one tryptophan and three argnine
residues, W500, R501, R503 and R505 in the sequence
are critical both for its interaction with nucleolin and for
HCV replication. We also confined that the long-turn
motif harbouring the RGG repeat in the nucleolin GAR
domain is essential for NS5B binding. These results
indicate that nucleolin is a critical host factor for HCV
replication through the direct interaction between W208
(41) and several residues in aa 500–505 of NS5B, and
the long-turn motif, including the RGG repeat, at the
C-terminus of nucleolin.
According to the crystal models, the sequence aa
500–506 is at the bottom part of the thick thumb of
NS5B, which comprises the four helixes of the armadillo
repeat (50). It is noteworthy that the sequence in the
helix, apart from the active pocket of the catalytic centre,
was found to be extremely sensitive to RdRp activity and/
or HCV replication. The neck of the big thumb seems to
be critical for the conformational change in NS5B,
involving the second GTP-binding site and the dimeric
interaction of NS5B (38, 50). Interestingly, five residues
(W500, R501, H502, R503 and R505) within the sequence
were found to be critical for HCV replication by alanine
scanning in the two HCV subgenomic replicon assays. All
the residues except H502 are essential for the binding
ability of NS5B to nucleolin, clearly demonstrating the
indispensable role of the interaction between NS5B and
nucleolin in HCV replication. The critical property of
H502 and R503 in HCV replication has been demon-
strated in the previous reports (50, 51). H502 is essential
for the homomeric interaction of NS5B that is prerequi-
site to RdRp activity (37, 38), and R503 is one of
the residues forming the GTP-specific binding pocket
(50, 52). By scanning the pm covering aa 500–506 of
NS5B, only H502 was found to be critical for RdRp
activity in vitro in the standard assay conditions (38),
where concentrations of enzyme and substrates are
much higher than those in HCV replication in vivo.
The interaction of nucleolin and NS5B may be necessary
for the active conformation of RdRp in vivo when
local concentrations of RdRp are limited. It is uncertain
at present whether NS5B interacts with NS5B and
nucleolin at the same time, but the interaction between
NS5B and nucleolin may happen before the conforma-
tional change of NS5B, or may be an intermediate
complex for the active conformation of RdRp or the
dimerization of NS5B. This notion seems to be consistent
to the facts that R503 is required both for GTP-binding
(38) and nucleolin-binding, and that the critical residues
for nucleolin-binding are distributed in different surfaces
of the helix which may interfere with the homomeric
interaction of NS5B. We tried to evaluate the importance
of tryptophan residue at aa 500 of NS5B by introducing
substitution, the mutant substituted to phenylalanine
or tyrosine but not to serine could bind GST-1234R in the
transient coexpression system, suggesting the impor-
tance of the aromatic residue at aa 500 in nucleolin-
binding, although NS5B harbouring W500F or W500Y
could not support HCV replication (data not shown).
The result may imply that the nucleolin-binding at aa
500 is not a sole function, or that only W500, not W500F
or W500Y may support the nucleolin-binding in HCV
replication in vivo when concentration of NS5B would be
much lower than that in the transient overexpression
system we applied.
We found that the sequence of nucleolin critical
for NS5B-binding lies within the GAR domain. The
GAR domain consists of an RGG repeats interspaced
with different amino acids and forms a beta-turn
structure (53). The GAR domain has been reported to
interact with various host factors, including single- and
double-stranded RNA and DNA (53), and several pro-
teins such as a ribosomal protein L3, hnRNP A1 and
some other hnRNP proteins (28). In some cases,
modification of arginine residue(s) of the GAR domain
has been shown to be involved in the interaction (28),
although such modification is not necessary for the
NS5B-binding as the interaction was observed among
the bacterial recombinant forms in vitro (34). Our results
here indicate that the NS5B-binding of nucleolin seems
to require several stretches of the RGG repeat within
GAR domain since at least two-thirds of RGG repeats
of the domain are important for binding NS5B by
scanning with versions of internal truncation and
alanine substitution mutations of arginine and phenyla-
lanine residues. The requirement of rather long sequence
in the GAR domain for NS5B-binding may be consistent
to the fact that the separated residues, W208 at the
exposed surface at the neck of palm and four residues
clustered at the bottom of thumb, are all required for the
nucleolin-binding.
We tried to evaluate the critical role of the interaction



















Fig. 7. Effect of truncated wild and mutant nucleolin on
HCV RNA replication. Cured MH14 cells were transfected
with in vitro transcribed LMH14 RNA using DMRIE-C reagent.
24 h after RNA transfection, plasmids encoding flag-tagged wild
or mutant nucleolin proteins were transfected using FuGENE6
reagent. Luciferase activity (relative light units; RLU) was
measured 24 and 72 h after RNA transfection. Shown are the
rations of activity (%) at 72 h relative to 24 h. Error bars indicate
the standard deviation of the results from at least three
independent experiments.
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truncated mutant of nucleolin missing the GAR domain
or the GAR domain alone in a transient over expression
system. However, both types of nucleolin mutants did not
affect much HCV replication. The result may be due to
the reason that HCV replication requires limited amount
of nucleolin in the cells as suppression of endogenous
nucleolin by siRNA only partially affected HCV replica-
tion (41). Alternatively, the truncated mutants may not
efficiently compete out endogenous nucleolin in the
system because the truncated mutants may not take
the same traffic pathway as that of endogenous nucleo-
lin. Biological functions of nucleolin have been reported
to play many roles in trafficking of RNA and/or
RNA-binding proteins, transcription activation, and
chromatin remodelling, and nucleolin has been reported
to be required for replication of some viruses (54, 55),
therefore, a possibility that some designs targeting to
nucleolin could inhibit HCV replication still remains
further explored.
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